Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Regeneron Has Strong Showing, But No REGEN-COV Sales Expected In First Half
Analysts Highlight Potential Growth Opportunities
Feb 04 2022
•
By
Alaric DeArment
Regeneron reported its fourth quarter and full year 2021 sales on 4 February • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business